Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: Andy Watson, Paul Grossman, Patrick Schnable

Premium

Andy Watson has left RainDance Technologies. Watson was hired in May 2011 as chief marketing officer and most recently served as chief commercial officer of the company. Previously, he was vice president of advanced genetic systems for Life Technologies.


Former Life Technologies executive Paul Grossman has joined Telegraph Hill Partners as a venture partner.

Grossman previously was head of global strategy and corporate development at Life Tech, and he also held the same position at Invitrogen. Before he joined Invitrogen, Grossman held a variety of leadership roles at Applied Biosystems, including as a research scientist and patent attorney, VP of intellectual property, and VP of strategy and business development.

Telegraph Hill Partners invests in commercial-stage life science, medical technology, and other healthcare companies, and manages $600 million across three funds.


Patrick Schnable has been named director of Iowa State University's Plant Sciences Institute.

Schnable is currently a professor in ISU's College of Agriculture and Life Sciences, and received the inaugural chair in genetics in ISU's department of agronomy in 2013.

He also founded and directs the Center for Plant Genomics, a center within the Plant Sciences Institute and served as the PSI's associate director from 2005 to 2010.

Separately, Schnable is managing partner of Data2Bio, a next-generation sequencing services firm.

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.